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RapidPlan software in generating clinically acceptable plans 
in a semi-automated manner for 5-field IMRT prostate 
treatments. Statistical guidance on exclusion of outliers 
appears somewhat conservative – inclusion of all available 
good quality plans should improve the scope and robustness 
of the model.  
   
EP-1433   
Treatment planning system geometric tools perfomances 
study with Qualiformed software  
A. Dupas1, D. Autret1 
1Institut de Cancérologie de l'Ouest, Medical Physics, Angers, 
France  
 
Purpose/Objective: The aim of this study is to evaluate the 
geometric performances of the treatment planning system 
(TPS) in external radiotherapy in order to identify its limits. 
Materials and Methods: Eclipse (Version 10) TPS was 
evaluated with the quality control software Digibox (version 
2.2). Digibox has a control points database, in which the 
operator selects some to create a set of control points that 
will be identified as a new quality control. For each control 
point of the quality control, Digibox prepares a digital test 
object (DTO) that automatically transfer to the TPS via the 
network. The operator then performs on the TPS the 
geometrical operation he wants to test. The test result is 
then returned to Digibox that analyses by comparing it with a 
theoretical result DTO. This study is composed of two 
sections. Section 1 deals with the beams display. Section 2 is 
about the definition of contours, margins, isocenter and the 
beams conformation. 
Results: 152 elementary geometrical operations were 
performed for a period of 14 hours of work, not included 
import and export times. The results of section 1 show no 
significant difference. The tests were: rotation of the 
collimator, beam angles, filed sizes and beam divergence. 
The results of section 2 showed however some important 
differences, especially on 3D margins for volumes with 
variable sections and small structures (<12 cm3), and the 
automatic positioning of the isocenter in complex structures. 
Minor discrepancies were identified on the conformation of 
the beams and jaws, the automatic contouring, and 
calculation of the volume of a structure showed less 
variation. 
Conclusions: Using Digibox, we could highlight two types of 
problems which one particularly concerns the stereotactic 
technique. This digital evaluation is an asset and can be used 
when an upgrade of the TPS is performed or to compare the 
performances of two TPS in the same department. Finally, 
the study of the definition of the bolus, the blocks, the 
distances calculation and the zoom tool are not yet possible 
with Digibox. 
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Purpose/Objective: To evaluate the performance of a 
knowledge-based DVH estimation constraints, namely 
RapidPlan, for optimising volumetric modulated arc therapy 
(RapidArc) applied to advanced lung cancer and to low risk 
prostate carcinoma patients.  
Materials and Methods: Two sets, one for lung and one for 
prostate cases, each of 27 previously treated patients, were 
selected to configure and train models for the estimation of 
dose-volume constraints to use in the optimization process. 
The models were subsequently validated on the same sets of 
27 plans each (closed-loop) and on further two sets each of 
25 patients not used for the training (open-loop). The two 
site groups differ mainly in the homogeneity of the 
characteristics: 
- Advanced lung cancer group: in-homogeneous dose 
prescription (50-70 Gy), wide variety of target volumes (67-
1193 cm3), two partial arc geometry 
- Low risk prostate group: homogeneous dose prescription (78 
Gy), modest variability of target volumes (80-421 cm3), single 
full arc geometry 
Analysis was based on DVH and statistics comparison between 
the RapidPlan and the original clinically accepted plans. 
Second endpoint was the evaluation of the pass-fail analysis 
for the two groups of plans based on consolidated criteria as 
following. For lung cases: D99%>95%(90%) and D1%<107% for 
CTV(PTV); mean<20Gy for ipsilateral, mean<15Gy and 
V20Gy<20% for contralateral lung; D1cm3<45Gy to spine; 
V45Gy<30% and V50Gy<20% for heart; D1cm3<70Gy and V30Gy<30% 
for oesophagus. For prostate cases: D99%>95% and D1%<107% for 
PTV; V70Gy<10%, V60Gy<40% and V50Gy<50% for rectum; V70Gy<30% 
and V60Gy<50% for bladder; Dmax<50Gy for femoral heads. 
Results: Average differences between the RapidPlan and the 
original plans of some dosimetric values are reported in the 
table (p values in parenthesis), where negative values 
indicate a superior mean plan quality of RapidPlan (the 
opposite for D99% for target). A significant improvement is 
shown for RapidPlan plans in both closed- and open-loop 
validations. 
 
 
 
In the pass-fail analysis, the rate of criteria not fulfilled was 
reduced in the lung patients group from 11% to 7% in the 
closed-loop and from 13% to 10% in the open-loop studies; in 
the prostate patients group it was reduced from 4% to 3% in 
the open-loop study. 
Conclusions: Plans were optimised using a knowledge-based 
model showed dosimetric improvements when compared to 
the original benchmark data, particularly in the sparing of 
organs at risk. The data suggests that the new engine is 
S776                                                                                                                                         3rd ESTRO Forum 2015 
 
reliable and could encourage its application to clinical 
practice. 
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Purpose/Objective: In recent years, there is a growing 
interest in combining MRI with external beam radiotherapy 
(EBRT). Moreover, the idea of gaining higher dose conformity 
by applying magnetic fields especially in electron beam 
therapy has been reported. In this work dosimetric impacts of 
transverse or longitudinal oriented uniform magnetic fields 
on the dose distribution from MeV electron beams for 
academic situations are investigated. 
Materials and Methods: Monte Carlo (MC) simulations were 
performed using the MC code GEANT4, which allows the 
simulation of magnetic fields. Dose distributions resulting 
from mono-energetic electron pencil-beams with 
perpendicular incidence on a homogeneous cubic water 
phantom were obtained for various combinations of magnetic 
field strengths B (0, 0.5, 1, 2, 3, 5 and 7 T) and initial 
electron energies E (1, 2, 4, 6, 10, 15, 20 and 25 MeV). Using 
the pencil beam dose distribution PDDs were calculated by 
lateral dose integration and broad beam dose distributions 
were generated by lateral superposition. Both parallel 
(longitudinal) and perpendicular (transverse) magnetic field 
orientations in relation to the beam direction were 
considered. The dosimetric impacts of magnetic field 
strength and orientation were evaluated for each beam 
energy by analysing the changes in characteristic features of 
the PDD and the lateral beam profile. In case of transverse 
magnetic field orientation, the paths of hypothetically 
unscattered electrons were calculated for various magnetic 
field strengths by solving the electrons relativistic equation 
of motion numerically. 
Results: A transverse magnetic field of 0.5 T already affects 
the central axis PDD of broad beams significantly. With 
increasing magnetic field strength the characteristic 
dosimetric features change strongly compared to the field-
free situation: e.g. for B = 7 T and E = 25 MeV the practical 
range Rp decreases by a factor of 10, the peak dose increases 
by a factor of 11 and the depth of dose maximum decreases 
by a factor of 19. The distance between the 80% dose levels 
and the penumbra (80%-20%) tend to decrease with increasing 
field strength. The peak to surface dose ratio exhibits a 
maximum at approx. B = 1 T for all beam energies. In case of 
longitudinal magnetic fields the central axis PDD of broad 
electron beams providing lateral electronic equilibrium 
remains unchanged. The lateral dose fall-off at the beam 
edges is steepened, e.g. for B = 7 T and E = 10 MeV the 
penumbra decreases by a factor of 4.3. The calculated 
trajectories of unscattered electrons reflect the high dose 
region of the corresponding pencil beam dose distributions. 
Conclusions: A transverse magnetic field confines the dose to 
shallow depths. Peak dose enhancement occurs due to 
spiraling electrons. Longitudinal magnetic fields primarily 
lead to penumbra reduction. The calculated electron 
trajectories are useful for interpretation of the dose effects 
observed.  
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Purpose/Objective: To evaluate the Dosimetric impact and 
the benefit of the HDR BT compared with RT in cutaneous 
tumors. 
Materials and Methods: two patients treated at CHRU Brest, 
patient 1 (P1) treated for no operated epidermal carcinoma 
of the lower lip, and patient 2 (P2) treated for an epidermal 
carcinoma of the right cheekbone, overflowing on the lower 
eyelid. P2 initially underwent an incomplete surgery with skin 
grafting. For two patients, dosimetric were calculated by the 
RT plans (Pinnacle Philips v8.0m) and the HDR plans 
(Oncentra-Elekta v4.1). CT scans were performed with a 
mask with and without cutaneous applicator. CTV and organs 
at risk (OARs) were defined. For P1, 7 fractions of 2.5Gy were 
prescribed in RT and HDR (ED of 18.2 Gy for a α/β=10). For 
P2 , 16 fractions of 3 Gy were prescribed in HDRBT(51,4Gy 
for a α/β=10) and 25 fractions of 2Gy in RT. In RT, a 6MVe 
beam was created for P1 and a 4MV beam for P2. In HDR, the 
dose was prescribed to 1cm of the source. The treatment was 
carried out with HDR Elekta-Nucletron’s with Ir192 source. 
Dose volume histograms (DVHs) over the 2 patients between 
these 2 techniques were compared. 
Results: For P1 : ED received by 2cm3 of the oral cavity was 
9.62Gy for the HDR and 23.2Gy for the RT. ED received by 
0.1cm3 of the upper lip was 5.6Gy for the HDR and 2.5Gy for 
the RT. Volume covered by 95% of the prescription dose was 
4.07cm3 in HDR and 20cm3 in RT, for a volume of CTV of 
1.9cm3. Both techniques achieved 100% coverage of the CTV. 
For P2 ED received by 0.1cm3 of the right crystalline lens was 
4.35Gy in HDR and 1.3Gy in RT. The ED received by 1cm3 of 
the right eye was 9.73Gy in HDR and 6Gy in RT. The volume 
covered by 95% of the prescription dose was 3.25cm3 in HDR 
and 6.17cm3 in RT, for a CTV volume of 1,54cm3. Both 
techniques achieved 100% coverage of the CTV. A sealed 
mask was set up during the treatment by HDR to decrease 
the eye’s dose. The volume of brain receiving 20Gy was 0cm3 
in HDR and 52cm3 in RT. 5 months after the end of the 
treatment by HDR, a scar aspect at the level of the lesion 
was found for P1, as well as a dug, but painless aspect. For 
P2, the follow-up one month and half found a dermatitis 
grade 1 limited to the level of the right cheekbone. 
Conclusions: Dosimetric results created by HDR plans were 
selected because its respected the dose constraints for OARs 
and allowed to decrease the volume of healthy tissue 
irradiated in depth. In HDR the schedule decreased the 
number of meetings what improved the comfort for the 
patient.  
   
 
 
 
 
